Literature DB >> 23360771

Reduced phosphorylation of GluA1 subunits relates to anxiety-like behaviours in mice.

Carly Kiselycznyk1, Xiaoqun Zhang, Richard L Huganir, Andrew Holmes, Per Svenningsson.   

Abstract

Anxiety and span>n class="Disease">depression are highly prevalent and frequently co-morbid conditions. The ionotropic glutamate receptors N-methyl-D-aspartate and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) mediate actions of monoaminergic antidepressants and have been directly targeted by novel fast-acting antidepressants. Less is known about the role of these receptors in anxiety-like states. Here we investigate how two distinct anxiolytic agents, buspirone, a partial 5-HT(1A) agonist, and diazepam, a benzodiazepine, influence phosphorylation of GluA1 subunits of AMPA receptors at the potentiating residue Ser(845) and Ser(831) in corticolimbic regions. To test the functional relevance of these changes, phosphomutant GluA1 mice lacking phosphorylatable Ser(845) and Ser(831) were examined in relevant behavioural paradigms. These mutant mice exhibited a reduced anxiety-like phenotype in the light/dark exploration task and elevated plus maze, but not in the novelty induced hypophagia paradigm. These data indicate that reduced potentiation of the AMPA receptor signalling, via decreased GluA1 phoshorylation, is specifically involved in approach-avoidance based paradigms relevant for anxiety-like behaviours.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23360771      PMCID: PMC3787598          DOI: 10.1017/S1461145712001174

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  27 in total

1.  Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines.

Authors:  E Izzo; J Auta; F Impagnatiello; C Pesold; A Guidotti; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory.

Authors:  Hey-Kyoung Lee; Kogo Takamiya; Jung-Soo Han; Hengye Man; Chong-Hyun Kim; Gavin Rumbaugh; Sandy Yu; Lin Ding; Chun He; Ronald S Petralia; Robert J Wenthold; Michela Gallagher; Richard L Huganir
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

3.  Antagonism of non-NMDA receptors in the dorsal periaqueductal grey induces anxiolytic effect in the elevated plus maze.

Authors:  M G Matheus; F S Guimarães
Journal:  Psychopharmacology (Berl)       Date:  1997-07       Impact factor: 4.530

4.  Effects of mild early life stress on abnormal emotion-related behaviors in 5-HTT knockout mice.

Authors:  Jenna C Carroll; Janel M Boyce-Rustay; Rachel Millstein; Rebecca Yang; Lisa M Wiedholz; Dennis L Murphy; Andrew Holmes
Journal:  Behav Genet       Date:  2007-01       Impact factor: 2.805

5.  Genotypic differences between C57BL/6 and A inbred mice in anxiolytic and sedative actions of diazepam.

Authors:  K M Garrett; I Niekrasz; D Haque; K M Parker; T W Seale
Journal:  Behav Genet       Date:  1998-03       Impact factor: 2.805

6.  The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders.

Authors:  Jing Du; Katsuji Suzuki; Yanling Wei; Yun Wang; Rayah Blumenthal; Zheng Chen; Cynthia Falke; Carlos A Zarate; Husseini K Manji
Journal:  Neuropsychopharmacology       Date:  2006-08-16       Impact factor: 7.853

7.  Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice.

Authors:  Jessica L Ihne; Paul J Fitzgerald; Kathryn R Hefner; Andrew Holmes
Journal:  Neuropharmacology       Date:  2011-09-02       Impact factor: 5.250

8.  Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit.

Authors:  K W Roche; R J O'Brien; A L Mammen; J Bernhardt; R L Huganir
Journal:  Neuron       Date:  1996-06       Impact factor: 17.173

9.  The putative AMPA receptor antagonist, LY326325, produces anxiolytic-like effects without altering locomotor activity in rats.

Authors:  J Kotlinska; S Liljequist
Journal:  Pharmacol Biochem Behav       Date:  1998-05       Impact factor: 3.533

10.  Baseline exploratory activity predicts anxiolytic responsiveness to diazepam in five mouse strains.

Authors:  J N Crawley; L G Davis
Journal:  Brain Res Bull       Date:  1982-06       Impact factor: 4.077

View more
  6 in total

Review 1.  Bisphenol A and its effects on the systemic organs of children.

Authors:  Sarah Zulkifli; Amirah Abdul Rahman; Siti Hamimah Sheikh Abdul Kadir; Noor Shafina Mohd Nor
Journal:  Eur J Pediatr       Date:  2021-04-24       Impact factor: 3.183

Review 2.  A Framework for Developing Translationally Relevant Animal Models of Stress-Induced Changes in Eating Behavior.

Authors:  Marie François; Olaya Fernández-Gayol; Lori M Zeltser
Journal:  Biol Psychiatry       Date:  2021-07-03       Impact factor: 12.810

3.  CaMKIIα knockdown decreases anxiety in the open field and low serotonin-induced upregulation of GluA1 in the basolateral amygdala.

Authors:  Lee Tran; N Bradley Keele
Journal:  Behav Brain Res       Date:  2016-01-26       Impact factor: 3.332

4.  Differential changes in amygdala and frontal cortex Pde10a expression during acute and protracted withdrawal.

Authors:  Marian L Logrip; Eric P Zorrilla
Journal:  Front Integr Neurosci       Date:  2014-04-08

5.  Secreted Amyloid Precursor Protein-Alpha Enhances LTP Through the Synthesis and Trafficking of Ca2+-Permeable AMPA Receptors.

Authors:  Rhys W Livingstone; Megan K Elder; Anurag Singh; Courteney M Westlake; Warren P Tate; Wickliffe C Abraham; Joanna M Williams
Journal:  Front Mol Neurosci       Date:  2021-04-01       Impact factor: 5.639

6.  Adolescent alcohol exposure produces sex differences in negative affect-like behavior and group I mGluR BNST plasticity.

Authors:  C R Kasten; K L Carzoli; N M Sharfman; T Henderson; E B Holmgren; M R Lerner; M C Miller; T A Wills
Journal:  Neuropsychopharmacology       Date:  2020-04-08       Impact factor: 7.853

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.